Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients? Reply

被引：0
作者：
Trollfors, B
Schneerson, R
Robbins, JB
机构：
[1] NICHHD, NIH, Bethesda, MD 20892 USA
[2] Goteborg Primary Hlth Care Syst, Goteborg Pertussis Vaccine Study, Gothenburg, Sweden
来源：
JOURNAL OF INFECTIOUS DISEASES | 2000年 / 182卷 / 05期
关键词：
D O I：
10.1086/315900
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1576 / 1577
页数：2
相关论文
共 50 条
  • [41] Seroprevalence of Pertussis Toxin Antibody in Manisa Province of Turkey, After Six Years Implementation of Acellular Pertussis Vaccine
    Ozbek, Ozgen Alpay
    Oktem, Ibrahim Mehmet Ali
    Hekimoglu, Can Huseyin
    Sekreter, Ozgur
    Emek, Mestan
    Atasoylu, Gonca
    Acikgoz, Ayla
    Demirpence, Nur
    Ceylan, Ali
    Baykal, Elif Sanem
    Unal, Belgin
    MIKROBIYOLOJI BULTENI, 2018, 52 (02): : 180 - 189
  • [42] Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
    Knuutila, Aapo
    Dalby, Tine
    Ahvenainen, Niina
    Barkoff, Alex-Mikael
    Jorgensen, Charlotte Svaerke
    Fuursted, Kurt
    Mertsola, Jussi
    He, Qiushui
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [43] Antibody and Cell-mediated Immunity to Pertussis 4 Years After Monovalent Acellular Pertussis Vaccine at Birth
    Wood, Nicholas
    Marshall, Helen
    White, Olivia J.
    Holt, Patrick G.
    McIntyre, Peter
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (05) : 511 - 517
  • [44] Adjuvant activity of acellular pertussis vaccine in tetanus vaccine
    Dias, W
    Esteves, MI
    Horton, D
    Gebara, V
    Furuyama, N
    Abreu, P
    Risoléo, L
    Silva, AP
    Raw, I
    IMMUNOLOGY 2004: IMMUNODEFICIENCY, INFECTIOUS DISEASES, IMMUNOMODULATION, AND VACCINES, 2004, : 333 - 336
  • [45] Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine
    Dalby, Tine
    Petersen, Jesper Westphal
    Harboe, Zitta B.
    Krogfelt, Karen Angeliki
    JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (09) : 1029 - 1036
  • [46] A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis
    Asokanathan, Catpagavalli
    Corbel, Michael
    Xing, Dorothy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (02) : 325 - 331
  • [47] Protection against pertussis
    Parang N. Mehta
    Indian Pediatrics, 2016, 53 : 679 - 683
  • [48] THE SAFETY OF ACELLULAR PERTUSSIS-VACCINE VS WHOLE-CELL PERTUSSIS-VACCINE
    ROSENTHAL, SR
    HABER, P
    CHEN, RT
    PEDIATRIC RESEARCH, 1995, 37 (04) : A114 - A114
  • [49] Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
    Hara, Megumi
    Fukuoka, Mami
    Tashiro, Katsuya
    Ozaki, Iwata
    Ohfuji, Satoko
    Okada, Kenji
    Nakano, Takashi
    Fukushima, Wakaba
    Hirota, Yoshio
    BMC INFECTIOUS DISEASES, 2015, 15 : 1 - 8
  • [50] Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort
    Witt, Maxwell A.
    Arias, Larry
    Katz, Paul H.
    Truong, Elizabeth T.
    Witt, David J.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1248 - 1254
12345